86 related articles for article (PubMed ID: 16434370)
21. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
Damm-Welk C; Klapper W; Oschlies I; Gesk S; Röttgers S; Bradtke J; Siebert R; Reiter A; Woessmann W
Br J Haematol; 2009 Aug; 146(3):306-9. PubMed ID: 19545284
[TBL] [Abstract][Full Text] [Related]
22. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
23. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.
Piva R; Agnelli L; Pellegrino E; Todoerti K; Grosso V; Tamagno I; Fornari A; Martinoglio B; Medico E; Zamò A; Facchetti F; Ponzoni M; Geissinger E; Rosenwald A; Müller-Hermelink HK; De Wolf-Peeters C; Piccaluga PP; Pileri S; Neri A; Inghirami G
J Clin Oncol; 2010 Mar; 28(9):1583-90. PubMed ID: 20159827
[TBL] [Abstract][Full Text] [Related]
27. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC.
Moritake H; Shimonodan H; Marutsuka K; Kamimura S; Kojima H; Nunoi H
Am J Hematol; 2011 Jan; 86(1):75-8. PubMed ID: 21080342
[TBL] [Abstract][Full Text] [Related]
28. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
29. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
Trinei M; Lanfrancone L; Campo E; Pulford K; Mason DY; Pelicci PG; Falini B
Cancer Res; 2000 Feb; 60(4):793-8. PubMed ID: 10706082
[TBL] [Abstract][Full Text] [Related]
30. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
Ait-Tahar K; Damm-Welk C; Burkhardt B; Zimmermann M; Klapper W; Reiter A; Pulford K; Woessmann W
Blood; 2010 Apr; 115(16):3314-9. PubMed ID: 20185586
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.
Mussolin L; Bonvini P; Ait-Tahar K; Pillon M; Tridello G; Buffardi S; Lombardi A; Pulford K; Rosolen A
Leukemia; 2009 Feb; 23(2):400-2. PubMed ID: 18615104
[No Abstract] [Full Text] [Related]
32. Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model.
Kreutmair S; Klingeberg C; Poggio T; Andrieux G; Keller A; Miething C; Follo M; Pfeifer D; Shoumariyeh K; Lengerke C; Gonzalez-Menendez I; Fend F; Zeiser R; Turner SD; Quintanilla-Martinez L; Boerries M; Duyster J; Illert AL
Leukemia; 2020 Dec; 34(12):3242-3255. PubMed ID: 32203142
[TBL] [Abstract][Full Text] [Related]
33. Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.
Stadler S; Singh VK; Knörr F; Damm-Welk C; Woessmann W
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29642597
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase: an oncogene for tumor vaccination.
Mastini C; Martinengo C; Inghirami G; Chiarle R
J Mol Med (Berl); 2009 Jul; 87(7):669-77. PubMed ID: 19330473
[TBL] [Abstract][Full Text] [Related]
35. Crizotinib in anaplastic large-cell lymphoma.
Gambacorti-Passerini C; Messa C; Pogliani EM
N Engl J Med; 2011 Feb; 364(8):775-6. PubMed ID: 21345110
[No Abstract] [Full Text] [Related]
36. Immune escape mechanisms in ALCL.
Oudejans JJ; ten Berge RL; Meijer CJ
J Clin Pathol; 2003 Jun; 56(6):423-5. PubMed ID: 12783967
[No Abstract] [Full Text] [Related]
37. PET/CT examination in an anaplastic malignant lymphoma with extensive reactive involvement.
Larsson P; Holzgraefe B; Kalzén H; Donnelly M; Porwit A; Jacobsson H
Clin Nucl Med; 2008 Sep; 33(9):619-20. PubMed ID: 18716511
[No Abstract] [Full Text] [Related]
38. Editorial: Tyrosine kinases and phosphatases in T- cell malignancies.
Tesio M
Front Oncol; 2024; 14():1372133. PubMed ID: 38371621
[No Abstract] [Full Text] [Related]
39. Challenging perspectives on the cellular origins of lymphoma.
Malcolm TI; Hodson DJ; Macintyre EA; Turner SD
Open Biol; 2016 Sep; 6(9):. PubMed ID: 27683157
[TBL] [Abstract][Full Text] [Related]
40. Giant-cell anaplastic lymphoma in an open thoracostomy cavity.
Ramos R; Ureña A; Martinez S; Spuch JA; Vallansot R
Cir Esp; 2015 Dec; 93(10):670-2. PubMed ID: 25438775
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
